Literature DB >> 21963123

A multidimensional computer adaptive test approach to dyspnea assessment.

Anna Norweg1, Pengsheng Ni, Eric Garshick, George O'Connor, Kira Wilke, Alan M Jette.   

Abstract

OBJECTIVES: To develop and test a prototype dyspnea computer adaptive test (CAT).
DESIGN: Prospective study.
SETTING: Two outpatient medical facilities. PARTICIPANTS: A convenience sample of adults (N=292) with chronic obstructive pulmonary disease (COPD).
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: We developed a modified and expanded item bank and CAT for the Dyspnea Management Questionnaire (DMQ), an outcome measure consisting of 4 dyspnea dimensions: dyspnea intensity, dyspnea anxiety, activity avoidance, and activity self-efficacy.
RESULTS: Factor analyses supported a 4-dimensional model underlying the 71 DMQ items. The DMQ item bank achieved acceptable Rasch model fit statistics, good measurement breadth with minimal floor and ceiling effects, and evidence of high internal consistency reliability (α=.92-.98). With the use of CAT simulation analyses, the DMQ-CAT showed high measurement accuracy compared with the total item pool (r=.83-.97, P<.0001) and evidence of good to excellent concurrent validity (r=-.61 to -.80, P<.0001). All DMQ-CAT domains showed evidence for known-groups validity (P≤.001).
CONCLUSIONS: The DMQ-CAT reliably and validly captured 4 distinct dyspnea domains. Multidimensional dyspnea assessment in COPD is needed to better measure the effectiveness of pharmacologic, pulmonary rehabilitation, and psychosocial interventions in not only alleviating the somatic sensation of dyspnea but also reducing dysfunctional emotions, cognitions, and behaviors associated with dyspnea, especially for anxious patients.
Copyright © 2011 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21963123      PMCID: PMC3526016          DOI: 10.1016/j.apmr.2011.05.020

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  42 in total

Review 1.  Health status assessment methods for adults: past accomplishments and future challenges.

Authors:  C A McHorney
Journal:  Annu Rev Public Health       Date:  1999       Impact factor: 21.981

Review 2.  Contemporary measurement techniques for rehabilitation outcomes assessment.

Authors:  Alan M Jette; Stephen M Haley
Journal:  J Rehabil Med       Date:  2005-11       Impact factor: 2.912

Review 3.  Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

4.  The catastrophic misinterpretation of physiological distress.

Authors:  M C Moore; B J Zebb
Journal:  Behav Res Ther       Date:  1999-11

5.  The promise of PROMIS: using item response theory to improve assessment of patient-reported outcomes.

Authors:  J F Fries; B Bruce; D Cella
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

Review 6.  Anxiety and self-management behaviour in chronic obstructive pulmonary disease: what has been learned?

Authors:  C A Dowson; R G Kuijer; R T Mulder
Journal:  Chron Respir Dis       Date:  2004       Impact factor: 2.444

7.  Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego.

Authors:  E G Eakin; P M Resnikoff; L M Prewitt; A L Ries; R M Kaplan
Journal:  Chest       Date:  1998-03       Impact factor: 9.410

8.  Differentiation between dyspnea and its affective components.

Authors:  V Carrieri-Kohlman; J M Gormley; M K Douglas; S M Paul; M S Stulbarg
Journal:  West J Nurs Res       Date:  1996-12       Impact factor: 1.967

9.  An explanatory model of functional status in chronic obstructive pulmonary disease.

Authors:  T E Weaver; T S Richmond; G L Narsavage
Journal:  Nurs Res       Date:  1997 Jan-Feb       Impact factor: 2.381

10.  Dyspnea as clinical indicator in patients with chronic obstructive pulmonary disease.

Authors:  N F Schlecht; K Schwartzman; J Bourbeau
Journal:  Chron Respir Dis       Date:  2005       Impact factor: 2.444

View more
  7 in total

Review 1.  Progress in Characterizing Patient-Centered Outcomes in COPD, 2004-2014.

Authors:  Paul Jones
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

2.  Working mechanism of a multidimensional computerized adaptive test for fatigue in rheumatoid arthritis.

Authors:  Stephanie Nikolaus; Christina Bode; Erik Taal; Harald E Vonkeman; Cees A W Glas; Mart A F J van de Laar
Journal:  Health Qual Life Outcomes       Date:  2015-02-21       Impact factor: 3.186

Review 3.  A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges.

Authors:  Mario Cazzola; Nicola Alexander Hanania; William MacNee; Katja Rüdell; Claire Hackford; Nihad Tamimi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-04-07

4.  Construct Validation of a Multidimensional Computerized Adaptive Test for Fatigue in Rheumatoid Arthritis.

Authors:  Stephanie Nikolaus; Christina Bode; Erik Taal; Harald E Vonkeman; Cees A W Glas; Mart A F J van de Laar
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

Review 5.  Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.

Authors:  Paul Jones; Marc Miravitlles; Thys van der Molen; Karoly Kulich
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-16

Review 6.  Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD.

Authors:  Anna Norweg; Eileen G Collins
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2013-09-25

7.  Activities Forgone because of Chronic Breathlessness: A Cross-Sectional Population Prevalence Study.

Authors:  Slavica Kochovska; Sungwon Chang; Deidre D Morgan; Diana Ferreira; Manraaj Sidhu; Rayan Saleh Moussa; Miriam J Johnson; Magnus Ekström; David C Currow
Journal:  Palliat Med Rep       Date:  2020-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.